Chemours cut to neutral from outperform by Mizuho; price target lowered to $15 from $18
CC•Mizuho cut its rating on Chemours to neutral from outperform and lowered its price target to $15 from $18.
CC•CC•CC•Mizuho cut its rating on Chemours to neutral from outperform and lowered its price target to $15 from $18.
